Skip to main content

Coagulation

1
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

vTv Therapeutics
vTv TherapeuticsNC - High Point
1 program
1
TTP889Phase 21 trial
Active Trials
NCT00909298Terminated2
Haemonetics
HaemoneticsMA - Boston
2 programs
RapidTEG MA ValidationN/A1 trial
Thromboelastography (TEG) Reference Range StudyN/A1 trial
Active Trials
NCT01428102Terminated17Est. Oct 2012
NCT01357928Completed159Est. Oct 2011
Entegrion
EntegrionNC - Durham
1 program
PCMN/A1 trial
Active Trials
NCT03133351Unknown240Est. Mar 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
vTv TherapeuticsTTP889
EntegrionPCM
HaemoneticsRapidTEG MA Validation
HaemoneticsThromboelastography (TEG) Reference Range Study

Clinical Trials (4)

Total enrollment: 418 patients across 4 trials

NCT00909298vTv TherapeuticsTTP889

Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA)

Start: Jun 20092 patients
Phase 2Terminated
NCT03133351EntegrionPCM

Reference Range Analysis of the Entegrion Point of Care Coagulation Monitor (PCM™) in Healthy Volunteers

Start: Apr 2017Est. completion: Mar 2021240 patients
N/AUnknown
NCT01428102HaemoneticsRapidTEG MA Validation

RapidTEG MA Validation

Start: Jul 2011Est. completion: Oct 201217 patients
N/ATerminated
NCT01357928HaemoneticsThromboelastography (TEG) Reference Range Study

Thromboelastography (TEG) Reference Range Study

Start: Apr 2011Est. completion: Oct 2011159 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.